Chandra Bhagat, a company in the Pharmaceuticals industry, reported revenue of ₹80 crore and net profit of ₹3.00 crore for the September 2026 quarter.
Chandra Bhagat (BSE: CBPL) closed at ₹67.00 on 20 Nov 2026, up 67.7% over the past year. Its market capitalisation is ₹51 crore and it trades at 9.7 times earnings.
Incorporated in 2003, Chandra Bhagat Pharma Ltd manufactures chemical and pharmaceutical products.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.